Decentralized Neuroplastogen Discovery
Blockchain-powered drug discovery merging human biology with decentralized research funding
The Streamlined Discovery Pipeline
Click through each phase to explore the process and see a live case study unfold.
Phase 1: Screening
Phase 2: Triangulation
Phase 3: Validation
Phase 4: Repurposing
Case Study: UDCA + Metformin
Follow the journey of a promising drug combination as it moves through the pipeline.
A Paradigm Shift in Discovery
Visualizing the advantages of the new streamlined approach over the previous LLM+DCM framework.
Key Feasibility Boosters
The core principles that make this framework efficient and effective.
Leverage Existing Data
Pre-train models on public datasets like Connectivity Map and UK Biobank to maximize insights and reduce cost.
Modular Workflow
Skip or defer resource-heavy steps like DCM and CLARITY until strong clinical signals emerge from earlier phases.
Fast Failure Principle
Use iPSC and behavioral assays as cost-effective gatekeepers to quickly eliminate non-promising candidates.
Repurposing Focus
Prioritize FDA-approved drugs with known human safety data to shorten timelines and de-risk clinical trials.
NeuroPlastoGen Token ($NPG)
A blockchain-powered utility token that funds research while giving investors access to groundbreaking discoveries before they hit mainstream medicine.
Research Access
- • Exclusive early access to research findings
- • API access to biomarker data streams
- • Premium analytics dashboards
Governance
- • Vote on research priorities
- • Propose new clinical trial designs
- • Influence IP allocation
Economic Model
- • 1-5% tokens burned per licensing deal
- • Quarterly token buybacks from royalties
- • Staking rewards from patent revenue
Token Allocation
- 45% Research Fund
- 20% Community
- 15% Team
- 12% Liquidity
- 5% Marketing
- 3% Advisors
Revenue Streams
Accelerating Discovery, Reducing Risk
This framework bypasses the biggest bottlenecks of previous models by replacing unvalidated parameters with direct biological measurements and swapping complex calibration for high-throughput triangulation. By focusing on empirical human biology and real-world outcomes, it offers a faster, more scalable, and clinically relevant path to discovering the next generation of neuroplastogens.
